Albert Goday Arno
Professor of Endocrinology in the Department of Medicine and Life Sciences at Pompeu Fabra University, Emeritus Head of the Endocrinology and Nutrition Service at Hospital del Mar in Barcelona and President of the Advisory Council on Diabetes in Catalonia of the Generalitat de Catalunya
It is a very interesting study. It is of good quality, because it does a new analysis, mortality and long-term, of a study, the UKPDS [English Prospective Diabetes Study], which has been emblematic and essential in diabetology for the last 40 years.
It fits that type 2 diabetes is a potentially serious and mortality-increasing disease, with no doubt about it. And it provides further evidence for the concept that type 2 diabetes is a heterogeneous disease, with subtypes with different prognoses, in this case depending on age.
[Regarding limitations] This study refers to people who were diagnosed with type 2 diabetes 40 years ago, and in those days the therapeutic offer was much more limited than today, which is better. Therefore, people with diabetes today will have a better long-term prognosis.